Dow Up 0.03% Nasdaq Up 0.32%

Progenics Pharmaceuticals, Inc. (PGNX)

-NasdaqGS
5.55 Up 0.04(0.73%) 10:55AM EDT - Nasdaq Real Time Price
Prev Close:5.51
Open:5.55
Bid:5.55 x 2500
Ask:5.56 x 1800
1y Target Est:9.50
Beta:1.41
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:5.50 - 5.62
52wk Range:3.10 - 7.45
Volume:353,815
Avg Vol (3m):1,434,050
Market Cap:386.04M
P/E (ttm):N/A
EPS (ttm):-0.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PGNX

Comparison

Symbol% ChgMkt Cap
PGNXUp 0.73%386.04M
DNDNUp 0.74%212.94M
NKTRUp 0.92%1.83B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):53.77
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.22
Quarterly EPS Est (Sep-14) :-0.15
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-1.00

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Progenics Pharmaceuticals, Inc. develops medicines for oncology. The company offers Relistor-subcutaneous injection for the treatment of opioid induced constipation (OIC) in advanced-illness patients receiving palliative care when laxative therapy... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback